Results 31 to 40 of about 352,837 (117)

Substandard and falsified medicines

open access: yes, 2021
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries.
SA (Amalia) Hasnida   +5 more
core   +1 more source

Digital drug screening to detect falsified, expired andrecalled medicines [PDF]

open access: yes, 2018
Falsified medicines are a global health and pharmaceutical sector issue which affect supply chains in low, middle and high-income countries. There are many methods to identify substandard and falsified medicines.
Naughton, Bernard David
core   +6 more sources

The falsified medicines directive and legal guarantees to ensure authenticity of medicines. The impact of drug serialization on medicine safety in the EU [PDF]

open access: yes, 2019
The aim of this study is to present the impact of the new legal solutions introduced in the so-called Falsified Medicines Directive on medicine safety in the EU.
Stych, Marek
core   +1 more source

What's in a Word? Falsified/Counterfeit/Fake Medicines - The Definitions Debate

open access: yesMedicine Access @ Point of Care, 2017
There is a rising tide of criminal activity to manufacture and distribute falsified, counterfeit, or fake medicines. The exact size of this problem is unknown but estimates vary from US$75 billion to US$200 billion per year, and evidence clearly ...
Mike Isles
doaj   +1 more source

Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study

open access: yesBMJ Open, 2016
Objectives To identify the authentication and detection rate of serialised medicines using medicines authentication technology.Design and intervention 4192 serialised medicines were entered into a hospital dispensary over two separate 8-week stages in ...
David Brindley   +4 more
doaj   +1 more source

Quality of antimalarial drugs and antibiotics in Papua New Guinea : a survey of the health facility supply chain [PDF]

open access: yes, 2014
Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient amounts of active pharmaceutical ingredients (API) endanger patient safety and may contribute to the ...
Betuela Inoni   +33 more
core   +2 more sources

EU POLICY AGAINST FALSIFIED MEDICINES: OPTIONS FOR FURTHER DEVELOPMENT [PDF]

open access: yes, 2020
The globalization of trade and internet access significantly increased the health risks associated with falsified medicines. International organizations, pharmaceutical companies and national governments developed a wide variety of measures to combat ...
Valcheva, Krasimira
core   +1 more source

Combating falsified medicines in Africa through digital artefacts [PDF]

open access: yes, 2016
Falsified medicines are again in the news, this time in a piece for the BBC News’ websites business section. In his article, Matthew Wall looks at the problem of combating falsified, counterfeit and substandard anti-malarial medicines in Africa through ...
Hibberd, Ralph
core   +5 more sources

2SPD-021 Noncompliance of datamatrix codes, an obstacle to implementation of the falsified medicines directive [PDF]

open access: yesSection 2: Selection, Procurement and Distribution, 2019
Background To reduce counterfeit drugs, the serialisation will become mandatory on 9 February 2019. A DataMatrix code will be used to encode each secondary packaging. This 2D barcode makes it possible to indicate an important number of traceability data in a small area.
S Cayeux   +4 more
openaire   +1 more source

Falsified Medicines, a Crime without Punishment [PDF]

open access: yes, 2017
Falsified medicines are a global threat that does not stop growing. Its trafficking causes more deaths than malaria while being more profitable than drug smuggling.
Quentin DUTEIL   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy